Clincosm LogoSign in Get a demo

HIV-1-infection

Showing NaN - NaN of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

Not yet recruiting
  • HIV-1-infection
  • ChAdOx1.tHIVconsv1
  • +7 more
  • San Diego, California
  • +11 more
Oct 4, 2023

HIV-1-infection Trial in United States (GS-5894, B/F/TAF, Standard of Care)

Recruiting
  • HIV-1-infection
  • Los Angeles, California
  • +15 more
Jan 13, 2023

HIV-1-infection, Adiposity, Insulin Resistance Trial in Brazil, United States (Semaglutide)

Active, not recruiting
  • HIV-1-infection
  • +4 more
  • Birmingham, Alabama
  • +7 more
Dec 7, 2022

HIV-1-infection Trial in United States (CVC 150 mg, CVC 300 mg, Placebo for CVC 150 mg)

Not yet recruiting
  • HIV-1-infection
  • CVC 150 mg
  • +3 more
  • Los Angeles, California
  • +16 more
Nov 22, 2022

HIV-1-infection Trial in Puerto Rico, United States (TMB-365/TMB-380)

Recruiting
  • HIV-1-infection
  • San Francisco, California
  • +6 more
Oct 25, 2022

HIV-1-infection Trial in Worldwide (Oral Lenacapavir, Oral Lenacapavir Placebo, Subcutaneous Lenacapavir)

Active, not recruiting
Has Results
  • HIV-1-infection
  • Oral Lenacapavir
  • +4 more
  • Los Angeles, California
  • +74 more
Oct 17, 2022

HIV-1-infection Trial in Worldwide (B/F/TAF, F/TAF, DTG)

Completed
Has Results
  • HIV-1-infection
  • Phoenix, Arizona
  • +93 more
Dec 14, 2021

INSTI-associated Weight Gain: a Focus on Energy Balance

Recruiting
  • HIV-1-infection
  • Weight Gain
  • Aurora, Colorado
  • +1 more
Jun 2, 2021

HIV/AIDS, HIV-1-infection, Osteopenia Trial in United States (Dolutegravir (DTG) 50MG/lamivudine (3TC) 300MG FIXED DOSE

Withdrawn
  • HIV/AIDS
  • +2 more
  • Dolutegravir (DTG) 50MG/lamivudine (3TC) 300MG FIXED DOSE COMBINATION (FDC)
  • Current tenofovir alafenamide (TAF)-containing ART regimen
  • Birmingham, Alabama
  • +9 more
Mar 10, 2021

HIV-1-infection Trial in Houston (Oral fecal microbiota transplantation)

Completed
  • HIV-1-infection
  • Oral fecal microbiota transplantation
  • Houston, Texas
    Thomas Street Health Center
May 24, 2020